MedPath

Accelerated 23-hour ERAS care for colorectal surgery.

Recruiting
Conditions
Maagdarmstelselaandoening: colorectale kanker
(inflammatory) bowel disease
colorectal cancer
10017969
Registration Number
NL-OMON52707
Lead Sponsor
Zuyderland Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

• Signed informed consent;
• Is >= 18 years <= 85;
• BMI <= 35 kg/m2;
• Is diagnosed with (non-complicated) colorectal cancer;
• Is scheduled to undergo elective laparoscopic colorectal surgery (right or
left hemicolectomy, transvers colon resection, recto-sigmoid resection with
primary anastomosis;
• Primary anastomosis is performed intracorporeally;
• Uncomplicated operation;
• Readily available ambulant care provided by an adult family member for the
first 24 hours after discharge;
• Patient is adequately reachable by phone.

Exclusion Criteria

• ASA classification > 3;
• Subjects who have limited mobility and/or need to be aided/assisted when
mobilizing;
• Subjects with a history of active pulmonary infection, any other active
infection, any uncontrolled medical disease
• Subjects with a contraindication for oral NSAIDs;
• Subjects with a contraindication for spinal anesthesia;
• Subjects requiring parenteral nutrition prior to surgery;
• Subjects scheduled to undergo lower rectal resections (TaTME, APR);
• Subjects receiving an ostomy;
• Subjects who experience complications preoperatively;
• Subjects who are mentally incompetent, challenged or requiring aid with daily
life activities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Rate of the successful and safe application of the 23-hour accelerated ERAS<br /><br>protocol for patients undergoing elective colorectal surgery. Success rate<br /><br>(feasibility) will be measured in readmission rate and safety will be measured<br /><br>with rate of serious adverse events (Clavien Dindo >=3b). Success rate<br /><br>(feasibility) will also be measured in percentage of patients who were not able<br /><br>to be discharged after 23 hours. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>• Demographic parameters<br /><br>• Disease related demographics<br /><br>• Comorbidities<br /><br>• Postoperative complications within 30 days<br /><br>• Postoperative mortality within 30 days<br /><br>• Short Nutritional Assessment Questionnaire (SNAQ)<br /><br>• Groningen Frailty Index (GFI)<br /><br>• Patient satisfaction evaluation </p><br>
© Copyright 2025. All Rights Reserved by MedPath